Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 16, 2024 11:21am
RE:RE:What's this?
Yeesh, that is a grand leap. But nice try. how could they pay me at my rates - they don't have that much money. The way you go hot and cold every second moment over the past week, and in the past
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Jan 16, 2024 11:08am
RE:RE:RE:RE:SBM falls after that news?
I am sure the offer will not be only for the private equity investor. It will be for the Investor and howie & friends & family. But definetly not for all shareholder.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:36am
RE:RE:RE:SBM falls after that news?
" I am personally not fussed here. It looks like there is more to the story around strategic investment that needs clarity, and whenever they get that figured out, we will likely go up again. JMO
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:31am
RE:What's this?
Well biorun, you seem to be on the company payroll, so don't you have the answers?
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 16, 2024 9:43am
RE:RE:SBM falls after that news?
I am personally not fussed here. It looks like there is more to the story around strategic investment that needs clarity, and whenever they get that figured out, we will likely go up again. JMO
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jan 16, 2024 9:39am
RE:SBM falls after that news?
One should keep i mind that not long ago the share traded at 8 cents. Fifty percent gain in two months is pretty good. Sell on news is a common strategy.
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jan 16, 2024 9:37am
What's this?
This has peaked my curiosity as to why TFC 1067 is not part of this. Is it because it's not in the end up for sale and this can't be repositioned under Sirona Laboratories due to the existing
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jan 16, 2024 8:09am
RE:RE:RE:SBM falls after that news?
Well hopefully this is the start of the split into two companies like Howie has been dangling out there for years - a pharma and cosmetic. Not sure how / where they are getting this money to
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 7:21am
RE:RE:SBM falls after that news?
Hopefully the "private" money is just debt of some kind, and not massive dilution to existing shareholders. Either way, those who have invested previously won't see the full benefit of
...more
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jan 16, 2024 4:01am
RE:SBM falls after that news?
You are right. I expect full transparency as to the people that will be behind the private capital that finances Sirona Laboratories. It is stated that “the company intends to finance the bulk
...more
(1)
•••
dimar66
X
View Profile
View Bullboard History
Post by
dimar66
on Jan 16, 2024 12:29am
Interesting Possibilities
The way SBM has been trading the last few weeks indicated that something was coming up. Short term traders must have dominated the market today. There seems to be something substantial
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jan 15, 2024 9:52pm
SBM falls after that news?
That pretty much sums up what investors think of the credibility of managment. Maybe that comment about "private" money funding the news subsidiary has people concerned they will siphon
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 15, 2024 4:05pm
RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
Yes, and you add the commercialization of TFC 1067 with Allergan and that number, in NPV terms per share, goes up another sizeable amount. When these guys announce private equity and ramp up details,
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jan 15, 2024 3:31pm
RE:RE:RE:RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
We tend to forget USD vs CAD. Deals usually refers to USD and the share is based on CAD. The conversion factor is usually 1.33 hence 0.48 cents in the example given.
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >